BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,081 filers reported holding BAXTER INTL INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,099 | +3.4% | 983 | +39.6% | 0.01% | -11.1% |
| Q2 2023 | $35,883 | 0.0% | 704 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $35,883 | 0.0% | 704 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $35,883 | -8.0% | 704 | 0.0% | 0.01% | -10.0% |
| Q3 2022 | $39,000 | -48.0% | 704 | -38.2% | 0.01% | -47.4% |
| Q2 2022 | $75,000 | -18.5% | 1,140 | -3.4% | 0.02% | -9.5% |
| Q1 2022 | $92,000 | -7.1% | 1,180 | +1.8% | 0.02% | -12.5% |
| Q4 2021 | $99,000 | -2.0% | 1,159 | -7.6% | 0.02% | -11.1% |
| Q3 2021 | $101,000 | 0.0% | 1,255 | 0.0% | 0.03% | +3.8% |
| Q2 2021 | $101,000 | -12.2% | 1,255 | -7.8% | 0.03% | -21.2% |
| Q1 2021 | $115,000 | -11.5% | 1,361 | -15.9% | 0.03% | -19.5% |
| Q4 2020 | $130,000 | -24.4% | 1,619 | -24.5% | 0.04% | +20.6% |
| Q3 2020 | $172,000 | -7.0% | 2,144 | 0.0% | 0.03% | -51.4% |
| Q2 2020 | $185,000 | -24.2% | 2,144 | -28.8% | 0.07% | -40.7% |
| Q1 2020 | $244,000 | -9.3% | 3,011 | -6.5% | 0.12% | +8.3% |
| Q4 2019 | $269,000 | -9.7% | 3,222 | -5.3% | 0.11% | +6.9% |
| Q3 2019 | $298,000 | +20.2% | 3,404 | +12.4% | 0.10% | +3.0% |
| Q2 2019 | $248,000 | +98.4% | 3,029 | +97.2% | 0.10% | +90.4% |
| Q1 2019 | $125,000 | -47.5% | 1,536 | -57.6% | 0.05% | -55.6% |
| Q4 2018 | $238,000 | – | 3,624 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |